CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Revenue Growth by Quarter and Year

Moderna Inc 's Revenue results by quarter and year




MRNA Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 570.75 0.13 -0.08
III Quarter September - 157.91 0.05 0.08
II Quarter June 4,354.00 66.35 0.07 -
I Quarter March 1,937.00 8.39 - -
FY   6,291.00 803.40 0.25 -



MRNA Revenue second quarter 2021 Y/Y Growth Comment
Moderna Inc reported Revenue surge of 6462.17% year on year in the second quarter, to $ 4,354.00 millions, this is lower than Moderna Inc 's recent average Revenue surge of 58068.71%.

Looking into second quarter results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Revenue growth. While Moderna Inc ' s Revenue doubling of 6462.17% ranks overall at the positon no. 26 in the second quarter.




MRNA Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 438938.46 % - -
III Quarter September - 315720 % -37.5 % -
II Quarter June 6462.17 % 94685.71 % - -
I Quarter March 22987.01 % - - -
FY   - 321260 % - -

Financial Statements
Moderna Inc 's second quarter 2021 Revenue $ 4,354.00 millions MRNA's Income Statement
Moderna Inc 's second quarter 2020 Revenue $ 66.35 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Revenue Growth >>


MRNA Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 261.44 % 160 % -
III Quarter September - 138 % -28.57 % -
II Quarter June 124.78 % 690.82 % - -
I Quarter March 239.38 % 6353.85 % - -
FY (Year on Year)   - 321260 % - -




Revenue second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #10
Overall #26

Revenue Y/Y Growth Statistics
High Average Low
431893.13 % 58068.71 % -100 %
(Dec 31 2020)   (Sep 30 2017)
Revenue second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #10
Overall #26
Revenue Y/Y Growth Statistics
High Average Low
431893.13 % 58068.71 % -100 %
(Dec 31 2020)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
6249.58 % 526.53 % -100 %
(Mar 31 2020)  


MRNA's II. Quarter Q/Q Revenue Comment
Moderna Inc achieved in the II. Quarter 2021 below company average Revenue doubling of 124.78% quarter on quarter, to $ 4,354.00 millions.

Within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 77.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #32
Overall #77
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #32
Overall #77
Revenue Q/Q Growth Statistics
High Average Low
6249.58 % 526.53 % -100 %
(Mar 31 2020)  


MRNA's II. Quarter Q/Q Revenue Comment
Moderna Inc achieved in the II. Quarter 2021 below company average Revenue doubling of 124.78% quarter on quarter, to $ 4,354.00 millions.

Within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Moderna Inc 's Revenue growth quarter on quarter, overall rank is 77.


Moderna Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Revenue 12 Months Ending $ 7,019.66 $ 2,732.01 $ 803.40 $ 232.78 $ 74.92
Y / Y Revenue Growth (TTM) 9269.14 % 31527.33 % 318707.54 % 532643.15 % 108671.82 %
Year on Year Revenue Growth Overall Ranking # 4 # 3 # 4 # 1 # 9
Seqeuential Revenue Change (TTM) 156.94 % 240.06 % 245.13 % 210.69 % 767.35 %
Seq. Revenue Growth (TTM) Overall Ranking # 17 # 9 # 24 # 20 # 37




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2021 period, Moderna Inc 's cumulative twelve months Revenue were $ 7,020 millions, company would post below average annual Revenue growth of 767.35% year on year, if the fiscal year would end at Jun 30 2021.
A slow-down in the Moderna Inc 's Revenue growth from the 1937% growth in Mar 31 2021.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3 to 4.

Revenue TTM Q/Q Growth Statistics
High Average Low
3327.83 %
673.52 %
-36.56 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 3
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
532643.15 %
200163.8 %
9269.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 7
S&P 500 # 17
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2021 period, Moderna Inc 's cumulative twelve months Revenue were $ 7,020 millions, company would post below average annual Revenue growth of 9269.14% year on year, if the fiscal year would end at Jun 30 2021.
A slow-down in the Moderna Inc 's Revenue growth from the 1937% growth in Mar 31 2021.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3 to 4.

Revenue TTM Q/Q Growth Statistics
High Average Low
3327.83 %
673.52 %
-36.56 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 3
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
532643.15 %
200163.8 %
9269.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 7
S&P 500 # 17




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MRNA's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MRNA's Competitors
Revenue Growth for Moderna Inc 's Suppliers
Revenue Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2021
Motus Gi Holdings Inc 9,900.00%$ 9,900.000 millions
Moderna Inc 6,462.07%$ 6,462.071 millions
Precision Biosciences Inc6,282.65%$ 6,282.653 millions
Revance Therapeutics Inc 6,188.96%$ 6,188.963 millions
Tg Therapeutics inc 3,965.79%$ 3,965.789 millions
Armata Pharmaceuticals Inc 3,667.74%$ 3,667.742 millions
Enzon Pharmaceuticals inc 3,537.50%$ 3,537.500 millions
Urogen Pharma Ltd 3,403.23%$ 3,403.226 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IONI's Profile

Stock Price

IONI's Financials

Business Description

Fundamentals

Charts & Quotes

IONI's News

Suppliers

IONI's Competitors

Customers & Markets

Economic Indicators

IONI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071